Verve Therapeutics (VERV.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Jul24

Eli Lilly's Acquisition of Verve Set to Complete

12:13

Jul15

Verve Therapeutics Launches Retention Bonus Plan for Executives

10:46

Jun28

BMO downgrades Verve Therapeutics

12:05

Jun18

FactSet analysts rate Verve Therapeutics as outperform with average target price

11:17

Jun17

Canadian Investment Bank Downgrades Verve Therapeutics' Rating and Target Price

15:04

Jun10

Verve Therapeutics Holds Annual Shareholders Meeting to Elect Directors

20:17

Schedules & Filings

Schedules

Filings

May14

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 32.98 M, Net Income -31.03 M, EPS -0.3494

Feb27

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 13.08 M, Net Income -50.04 M, EPS -0.5759

Nov5

Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 6.865 M, Net Income -50.13 M, EPS -0.5923

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change